newsfilter
← Latest News
GlobeNewswire·

Mydecine Reports Third Quarter 2021 Financial Results and Provides Business Update

--To Launch Phase 2/3 Smoking Cessation Clinical Trial with Johns Hopkins University (JHU) Signed 5-Year Research Agreement with JHU to Further Mydecine's Research of Multiple Molecules for a Variety of Indications -- DENVER, Nov. 16, 2021 (GLOBE